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Systemic lupus erythematosus (SLE), in mice as in humans, is characterized by
awide spectrum ofautoantibodies mainly directed at cellular antigens (1, 2). T cells
are apparently required for the induction of such autoantibodies, but their exact
rolein spontaneousdisease remains tobedefined (3, 4). In chronic graft-versus-host
(GVH)' disease, an SLE-like syndrome can be induced in normal mice by transfer
ofallogeneic Tcells. It isthoughtthattheallohelper Tcells ofthe donor react against
incompatible la structures of the host and generate excessive help, which activates
a subpopulationofBcells inthehost thatis selfreactive (5-7). SuchaGVH reaction
occurs between B6 (orits Igh allotypecongenicstrain B6.C20) andbm12mice through
the recognition of the mutant bm12 Ia by the B6 (or B6.C20) cells, and vice versa
(6; and Morris, S. C., P L. Cohen, and R. A. Eisenberg, manuscript submitted
forpublication). Asyndrome that closely resembles SLE is induced, with autoanti-
bodies to erythrocytes, chromatin, nuclear antigens, and to a more limited degree,
double-stranded DNA.
Activationofresting Bcells to proliferateanddifferentiate into antibody-producing
cells occurs through the binding of antigen by the B cell surface Ig receptor and
the participation ofT cell help. Previous studies have established that Th cells can
support antigen-specific B cell responses through two distinct pathways (8-13). Cog-
nate help results from direct T-B contact, while noncognate or bystander help is
mediated through factors released from activated Tcells that can act at a distance
upon antigen-activated B cells. Since chronic GVH results from the stimulation of
alloreactive Thelper cells (14), and their inappropriate collaboration with the host
Bcells(5, 15), weinvestigated whether the donorTcells recognized foreignladirectly
on the B cell stimulated to make autoantibodies. Double-congenic chimeras, con-
taining two sets of B cells that differed at both Ia and Igh allotype, were used to
determine whether the autoantibody forming cells were specifically stimulated by
the autoreactive T cells and/or if a bystander effect was occurring. The isotype and
allotypeofthe Coombs antibodieswere determined, aswas the allotype ofthe IgG2a
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and IgM antichromatin antibodies. We found that autoantibody production resulted
almost entirely from cognate recognition (direct T-B contact).
Materials and Methods
Experimental Animals.
￿
C57BL/6Kh (B6: H-26, Ighb), B6.C-H-26"''2 (bm12: H-2b.12, Ighb),
B6.C20 (H-26, Igha), and (B6.C20 x bml2)Ft mice were maintained in our breeding facility.
The B6 and bm12 mice were originallyobtained from Roger Melvold (Northwestern Univer-
sity, Chicago, IL), and the B6.C20 mice were from Gayle Bosma (Institute for Cancer Re-
search, Philadelphia, PA). All mice used in this study were female. Mice were entered into
two separate experiments at different times. As the results with these two cohorts were en-
tirely comparable, pooled data for all mice are presented.
Antibodies (Table I).
￿
Monoclonal anti-isotype/allotype antibodies or control antibodies were
either obtained commercially, or isolated from ascites or tissue culture supernatants (HB100,
TIB148, 2E.6, 4F3, and MPCII). Ascites was produced in mice with the appropriate H-2
and Igh allotypes.
Production of Chimeras (Table II).
￿
Recipient (B6.C20 x bm12)F, mice, 2-5 mo old, were
given neomycin sulfate in theirdrinking waterfor 48 h before irradiation and for a minimum
of8 wk thereafter. They received 850-900 rad in a Gamma-Cell 40 apparatus (Atomic Energy
of Canada, Ltd., Ottawa, Ontario, Canada) on the morning of bone marrow transfer. The
mice were reconstituted intravenously with 1.25-1.5 x 107 F, or parental bone marrow cells,
obtained from the tibias and femurs of 2-7-mo-old mice and treated with monoclonal anti-
Thy-1.2 (NEN Research Products, Boston, MA) plus complement. 4-5 mo afterbone marrow
repopulation, recipients were checked for chimerism by flow cytometry of their peripheral
TABLE I
Monoclonal Reagents
' HB100 was specific in our ELISAs and in our Coombs assay, but was not
able to be used by us for staining.
t Monoclonal used as antigen for standardizations .
Name Source (reference) Species Isotype
Antibody
specificity
HB100 (Bet 1)' ATCC (16) Rat IgGI IgM'
AF6-78.25.2 Stall (17) Mouse IgGI IgMb
20-9.10 Oi (18) Mouse IgG2a IgGla
412-14.4 Oi Mouse IgGl IgGl b
TIB148 (Ig(la)8.3) ATCC (18) Mouse IgG2a IgG2a'
Ig(16)3 .1 .5.9 Oi (18,19) Mouse IgGl IgG2ab
21-48.1 Oi Mouse IgG2a IgG2ba
412-72 .1 Oi Mouse IgGI IgG2bb
2E.6 ATCC Rat IgGl IgG3
D3-137.5 Tonkonogy Mouse IgG2a I-Ab
MOPC21 Litton Mouse IgGI' -l
MOPC245 Potter Mouse IgGlb -
HB63 (1-29-7) ATCC (20) Mouse IgG2aa -
4F3 Ross Mouse IgG2aa -
CBPC101 Potter Mouse IgG2ab -
MPC1I ATCC (21) Mouse IgG2ba -
MOPC 195 Litton Mouse IgC2ba -
BPC4 Potter Mouse IgG2bb -
J606 Litton Mouse IgG3 -
FLOPC21 Litton Mouse IgG3 -
TEPC183 Litton Mouse IgMa -
CBPC112 Potter Mouse IgMb -MORRIS ET AL.
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TABLE II
GVH Chimeric Mice
blood lymphocytes. Briefly, 25014 of peripheral blood wascollected in heparin, diluted with
250111 of PBS, andlayered over 500111 of Lympholyte M(Cedarlane Laboratories, Hornby,
Ontario). After centrifugation and washing, thecells were stained for I-Ab with biotinylated
mAb D3-137.5 (IgG2a), and for IgMb with mAb AF6-78.25.2 (IgGI). For two-color anal-
ysis, streptavidin-phycoerythrin (Becton Dickinson & Co., Mountain View, CA) and
fluorescein-labeled goat anti-mouse IgGl (Southern Biotechnology Associates, Birmingham,
AL) were used as the second-step reagents.
Induction of GVHDisease (Table II).
￿
GVH disease was induced in chimeric mice by in-
jecting intraperitoneally 10' viable parental spleen cells from 5-9-mo-old donors. F, spleen
cell injected mice served as controls. Single cell suspensions were prepared by pressing the
spleens through a mesh wire screen into HBSS. Thecells were washed three times in HBSS
before injection.
Follow-up ofMice.
￿
Mice were bled at intervals of 2-5 wk by retro-orbital sinus puncture
underether anesthesia. 50 141 of blood, diluted in Alsever's solution (2.05% dextrose, 0.43%
NaCl, and 0.8% sodium citrate), was taken for the determination of antierythrocyte anti-
bodies (Coombs). Additional bloodwasclotted, and the serum separatedand stored at -20°C
for future testing.
Determination ofAnti-Mouse Erythrocyte (Coombs) Antibodies.
￿
The direct Coombs test forthe
detection ofboundantierythrocyte antibodies wasperformedwith a 1% suspension of washed
mouse erythrocytes in PBS containing 1% heat-inactivated FCS. 501a,1 of rabbit anti-mouse
,y(heavy andlightchain specific), diluted 1:20, were placed in around-bottomed polystyrene
microtiter plate(Dynatech Laboratories, Inc., Alexandria, VA) and 501i1 ofthe erythrocyte
suspension wasadded. As anegative control, 501i1 of bufferalonewasmixedwith theerythro-
cytes. The microtiter plates were scored for hemagglutination on a scale of 0 to 4+.
Determination ofthe IsotypeandAllotype of the Coombs Antibodies.
￿
Purified mAbs (see Table
I) specific for either the a or b allotype of the isotypes -yl, y2a, y2b, or IgM, as well as a
mAb specific fory3 (y3 is not polymorphic in inbred mice), were coated on sheep erythro-
cytes (SRBC) by the CrC13method (22). Monoclonal control proteins of theaor b allotype
for each isotype were also coated on SRBC and used to confirm the specificity of the SRBC
coated with the anti-isotypelallotype reagents. To validate the assay, erythrocytes were
resuspended to 0.5% in PBS containing 1% heat-inactivated FCS, and equal mixtures of
the anti-isotypelallotypeprotein-coated SRBC were mixedwith monoclonal control protein-
coated SRBC and scored forhemagglutination. The isotype and allotype of the GVH anti-
MRBC antibody were then determined by mixing 501~1 of a 0.5% suspension of Coombs-
positive erythrocytes with 50 Al of antibody-coated SRBC in a polystyrene microtiter plate.
The results were scored for hemagglutination on a scale of 0 to 4+ .
Determination ofSerum IgG2bb Levels.
￿
A hemagglutination assay for the estimation of rel-
ative serum levels of IgG2bb was performed using SRBC coated with anti-IgG2bb-purified
mAb as described above. 501il of a 1% suspension of antibody-coated SRBC was mixed with
50 10 of serum diluted serially twofold from 1:1,000 to 1:16,000 in a polystyrene microtiter
plate. The results were scored for hemagglutination.
ELISA ofIgGandIgMAntichromatin.
￿
Chromatinantigen waspurified from chicken eryth-
rocyte nuclei (23). Polyvinylchloride microtiter plates (Dynatech Laboratories, Inc.) were
coated with 100 1x1 of a 101r,g/ml chromatin solution in borate-buffered saline (BBS) for 5 h
Group Bone marrow donor B cell phenotype Spleen cell graft
I (B6.C20 x bm12)F, Igha,H-26/6-12 and Ighb,H-26/6.12 bm12
II
11 11 B6
III B6.C20 and bml2 Igha,H-26 and Ighb,H-26-12 bml2
IV
11 B6
V (B6.C20 x bm12)F, Igha,H-2b1bm12 and Ighb,H-2blbm12 (B6.C20 x bml2)Fl
VI B6.C20 and bm12 Igha,H-26 and Ighb,H-26-12 (M.C20 x bm12)F,506
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at room temperature. The plates were then washed with BBS and incubated with 200 Wl of
coating buffer (BBS, 0.5% normal goat serum, 0.4% Tween 80, 0.5% BSA, and 0.1% NaN3)
for 2 h at room temperature. After washing the plates, serum samples diluted 1 :500 in coating
buffer were added. The plates were incubated overnight at 4°C. The following day, the plates
were washed and a 1/4,000 dilution ofbiotinylated affinity-purified goat anti-mouse IgG (pFc'
specific) or a 1/500 dilution of goat anti-mouse IgM (heavy chain specific) were added for
1 h at 4°C. The plates were then washed and incubated with avidin-alkaline phosphatase
(Zymed Laboratories, So. San Francisco, CA) for 1 h at 4°C. After washing, paranitrophenyl
phosphate substrate (Sigma Chemical Co., St. Louis, MO) was added in 0.01 M diethanola-
mine, pH 9.8. The plates were read at multiple time points with an automated micro-ELISA
reader (Dynatech Laboratories, Inc.). The anti-IgG and anti-IgM reagents were standardized
to each other, and the results from individual assays were standardized against a high titer
MRL/Mp-lpr/lpr mouse serum, and equivalent dilution factors (EDF) were calculated ac-
cording to the following formula: (Dilution ofstandard reference sera that gives the equiva-
lent OD of the test serum) x 106 (24). Sera were considered positive for antichromatin anti-
bodies if they exhibited an EDF value >15 .
ELISA ofAllotype-speckAntichromatin.
￿
The allotype of IgG2a and IgM antichromatin an-
tibodies was quantitated by an assay similar to that for IgG and IgM antichromatin, except
that the serum was diluted 1 :250 and the assay was developed with standardized biotinylated
monoclonal antiallotype reagents (anti-IgG2aa, anti-IgG2ab, anti-IgM', or anti-IgMb). The
relative amounts of a and b allotype IgG2a antichromatin antibodies in the test sera were
determined by comparison with standard sera from a MRL/Mp-lpr/lpr mouse (Ighi, equiva-
lent to Igh') and from a C57BL/6-lpr/lpr mouse (Ighb). These sera were chosen to have
equivalent amounts of IgG2a antichromatin antibodies, such that the results of the IgG2a'
and IgG2ab assay could be expressed as comparable EDF. In the IgM' and IgMb allo-
type-specific assay, the C57BL/6-lpr/lpr and the MRL/Mp-lpr/lpr reference sera were vali-
dated in every assay by developing with goat anti-mouse IgM. These results were also ex-
pressed as EDF.
ELISA of Total Serum IgG2a° and IgG2ab.
￿
Total serum IgG2a of the a or b allotype was
measured by coating the microtiter plates with rat anti-mouse K chain mAb (HB58, ATCC)
at a concentration of 0.1 jig/well. The plates were then washed and incubated with coating
buffer. After washing the plates, the sera were added, diluted to 1 :10,000 and 1 :100,000,
for an overnight incubation. The plates were washed, and biotinylated monoclonal anti-
IgG2a' and anti-IgG2ab reagents were added in the presence of excess mouse IgG myeloma
ascites of the opposite allotype (e.g., anti-IgG2a' was mixed with b allotype ascites) in order
to block free binding sites of the rat anti-mouse K antibody. After incubating the biotinylated
reagent for 2 h the plates were washed, and avidin-alkaline phosphatase was added for 2 h,
followed by paranitrophenyl phosphate substrate. The results from individual assays were
standardized with purified monoclonal IgG2a' or IgG2ab proteins, and the results were ex-
pressed as micrograms per milliliter.
ELISA of Total Serum IgM° and IgMb.
￿
Serum levels of IgM' and IgMb were measured by
a modification of the serum IgG2a allotype ELISA. Microtiter plate wells were coated with
affinity-purified goat anti-mouse IgM. The remainder of the assay was the same except that
the sera were tested at dilutions of 1 :2,000 and 1 :4,000, and the assay was developed with
biotinylated monoclonal anti-IgM (a or b allotype specific) reagents without excess ascites
being present. The results were standardized with IgM' and IgMb myeloma proteins, and
the results were expressed as micrograms per milliliter.
Results
Generation of Chimeras.
￿
To study whether self-reactive host B cells are activated
by direct interaction with alloreactive T cells or by nonspecific bystander effects,
we generated two types of chimeras. Specifically, (B6.C20 x bml2)FI mice, hetero-
zygous for la (lab/Iab"12) and for Igh allotype (Igha/Ighb), were irradiated and
reconstituted with either an equal mixture ofbm12 and B6.C20 marrow cells ("double-parental chimeras"); or with Fl marrow ("control chimeras"). Individual B cells in
the double-parental chimeras should express either Ighb and labml2, or Igha and lab;
while B cells of the control chimeras should express either Igha or Ighb together with
lab/labm12. T o verify appropriate bone marrow reconstitution, all of the double-
parental chimeras and some ofthe control chimeras were subjected to two-color im-
munofluorescence flow cytometric analysis of cell surface IgMb and I-Ab expression
on theirPBL. Double-parental chimeras PBL showed amean percentage ofdouble
staining for IgMb and lab of only 1.9% t 0.2 (n = 35), which is no different (P
= 0.29) than that seen with a control mixture of equal numbers of PBL from bm12
and B6.C20 mice, 1.2% ± 0.4 (n = 4). These results demonstrated that double-
parental chimeras were indeed reconstituted with a mixture of parental cells, and
that the host (F,) B cells did not recover significantly. Control (F, reconstituted)
chimeras, in contrast, had 9.9% t 1.2 (n = 11) double staining for IgMb and lab.
Induction ofa Chronic GVHSyndrome.
￿
Double-parental chimeras (groups III, IV,
and VI) and F,-reconstituted chimeras (groups 1, II, and V) were each injected with
108 B6, bm12 or (B6.C20 x bm12)F, spleen cells (Table II). A chronic GVH syn-
drome was evident in those chimeras that received B6 or bm12 spleen cells (groups
I-IV), as indicated by accelerated 50% mortalityby 9-16 wk (Fig. 1), antichromatin
and Coombs autoantibodies peaking at 5-9 wk (see below), and transient ascites
not associated with proteinuria (data not shown).
AntierythrocyteAntibodies.
￿
As shown in Table III, the numbers of mice that were
Coombs-positive ranged from 25% of the mice in group I to 100% of the mice in
group IV, All samples found to be direct Coombs-positive by hemagglutination were
then screened for both the isotype and allotype oftheiranti-MRBC antibodies. IgM
and all four IgG subclasses of anti-MRBC antibodies appeared without any evi-
denceforisotype preference. Not allCoombs-positive samples were able to be typed
for isotype and allotype.
Table IV compiles the allotypes of the Coombs antibodies from all weeks tested.
Only a allotype was detected in Coombs-positivemice in group II and in group III.
In contrast, group IV mice had predominantly b allotype anti-MRBC antibodies,
although three of these mice had IgG2aa anti-MRBC antibodies in several bleeds,
as well as b allotype anti-MRBC antibodies of various isotypes.
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FIGURE 1 . Survival of GVH chimera mice.
GVH disease wasinduced in chimeras by injec-
tion of either bm12 or B6 spleen cells. A mor-
tality of 50% occurred in the four experimental
groups between weeks 9 and 16. The n listed
represents thetotal number ofmice that started
in each group(Table III). Groups I (*) n = 12,
group 11 (O) n = 11, group111 (0) n = 15, and
group IV (A) n = 16. The two control groups
(/), group V (n = 7), and group VI (n = 9)
were pooled.508
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TABLE III
Antierythrocyte Antibodies in Chimeric GVH Mice
` Every Coombs-positive bleed for each mouse was tested with the panel of anti-allotype/isotype-specific
mAb-coated SRBC . Numbers presented represent the number of mice in each group for which a particu-
lar isotype occurred at least once .
Antichromatin Antibodies.
￿
The serum levels of both IgG and IgM antichromatin
autoantibodies were assessed by ELISA (Table V). 44ofthe 49 mice in groups I-IV
were positive for IgG antichromatin autoantibodies, and 38 were positive for IgM
antichromatin autoantibodies. In the mice with both IgG and IgM antichromatin
antibodies, the initial IgM and IgG response generally coincided, although IgM
tended to peak early and then diminish, while IgG continued to increase. The peak
titers of IgG antichromatin antibodies were higher than those of IgM. As we have
found in other GVH mice, IgG2a was the predominant subclass of the IgG an-
tichromatin responses (data not shown).
Allotype oftheAntichromatinAutoantibodies.
￿
The amountsofa and b allotype IgG2a
antichromatin autoantibodies were quantitated for the mice in groups I-IV at all
time points. Fig. 2 shows the titers of the IgG2aa and IgG2ab antichromatin anti-
bodies foreach mouseat itspeak IgG antichromatin response. Group III mice were
only positive for IgG2aa and group IV for IgG2ab antichromatin antibodies. This
patternheld truethroughoutthecourse ofthe experiment (datanot shown). Ingroups
I and II, both allotypes were seen, although a preference for IgG2ab antichromatin
antibodieswasevident, since all ofthe mice except two were to the left ofthe equiva-
lence line (IgG2ab equals IgG2aa).
Fig. 3 shows the results for the IgM antichromatin allotypes, which were deter-
mined at the peak IgM titer week in IgM antichromatin-positive mice. The IgM
TABLE IV
Coombs Allotype in Chimeric GVH Mice
' Every Coombs-positive bleed for each mouse was tested with the panel ofanti-
allotype/isotype-specific mAb-coated SRBC . Numbers presented represent the
sums of positive reactions of the a and b allotypes, respectively.
Group n Coombs-positive -yl
Isotype
-y2a
detected`
y2b -y3 k
I bm12-(B6.C20 x bm12)Fi 12 3 0 0 0 1 0
II B6-(B6.C20 x bml2)Fl 11 6 4 1 0 5 0
III bm12-B6 .C20 + bm12 13 10 7 3 0 4 0
IV B6-B&C20 + bm12 13 13 5 8 8 11 12
V (B6.C20 x bml2)Fl-(B6 .C20 x bm12)Fl 6 0 - - - - -
VI (B6.C20 x bml2)Fi-B6.C20 + bml2 9 0
Group n
Allotype"
a b
I bm12-(B6.C20 x bm12)Fl 12 0 0
II B6-(B6.C20 x bm12)Fj 11 10 0
III bm12-B6 .C20 + bm12 13 14 0
IV B6-B6.C20 + bml2 13 8 721000
100
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TABLE V
IgG and IgMAntichromatin Antibodies in Chimeric GVH Mice
" Mice were positive for antichromatin antibodies if the EDF was >15 .
1 Geometric means of the peak EDF for all mice in the group . Standard errors (x/+) were 1 .1-1 .3 .
a allotype (EDF)
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FIGURE 2. Allotypes of IgG2a antichro-
matin antibodies in chimericGVHmice .The
levels of IgG2a' and IgG2ab antichromatin
antibodies, for the peak IgG antichromatin
week, areshown for themice that were posi-
tive forIgG antichromatin antibodies (EDF
>15). Group I (/), group II (A), group III
(p), and group IV (A) .
FIGURE 3 .
￿
Allotypes of IgM antichro-
matin antibodies in chimericGVH mice .
The levels of IgM' and IgMb an-
tichromatin antibodies, for the peak IgM
antichromatin week, are shown for those
mice that hadanEDFof>20 forIgM an-
tichromatin antibodies . Group I (/),
group II (A), group III (p), and group
IV (A) .
antibodies in group III were strongly skewed to the a allotype, while those in group
IV were skewed to the b allotype . In contrast to the IgG2a results, however, IgM
anti-chromatin antibodies of the b and a allotypes were present in groups III and
IV, respectively, albeit in low titers . In thecontrol chimeras (groups Iand II) a slight
Group n
Number
IgG
positive"
IgM
Titert
IgG IgM
I bm12-(B6.C20 x bml2)Fi 12 12 12 102 52
II B6-(B6.C20 x bm12)Fl 11 7 5 25 19
III bml2-B6 .C20 + bm12 13 13 11 110 35
IV B6-M.C20 + bm12 13 12 10 77 20
V (B6.C20 x bml2)F,-(B6.C20 x bml2)Fl 6 2 1 13 11
VI (B6.C20 x bml2)Fj-B6.C20 + bm12 9 2 0 10 751 0
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TABLE VI
Total Serum IgG2a Allotype in IgG Antichromatin-positive
Chimeric GVH Mice
' Results shown are from bleeds with highest IgG anti-chromatin titers (see
Fig. 2).
1 Arithmetic mean (,ug/ml).
preference for IgM antichromatin antibodies ofthe b allotype was seen, since data
from all of the mice, except one, were slightly to the left of the equivalence line
(IgMa equals IgM').
Total Serum Allotype Levels ofIgG2a andIgM.
￿
The total serum levels ofboth IgG2a
and IgM were determined for the a and b allotype. Table VI summarizes the data
for total serum IgG2a for both allotypes in the same bleeds in which IgG2a an-
tichromatin allotypes were measured for IgG antichromatin-positive mice. In the
double-parental chimeras (groups III and IV), the prebleed levels of IgG2aa and
IgG2a' were comparable. At the peak titer week, group III mice showed an increase
in IgG2aa and a decrease in IgG2a' as compared with their prebleed levels. In con-
trast, group IV mice showed an increase in IgG2a' and a decrease in IgG2aa.
Table VII showssimilardata for the IgM allotypes. In the double-parental chimeras,
groups III and IV, the prebleed levels ofIgMa and IgM' were comparable. At the
peak titer week, group III mice showed a significant increase in IgMa (P < 0.0001)
and an insignificant decrease in IgM' (p = 0.53), as compared with their prebleed
levels. Group IV mice showed reciprocal results.
The mean decrease in IgG2a' in group III and in IgG2aa in group IV reflected
a strikingallotype-specific suppression ofIgG2aasearly as the first bleed afterGVH
induction (week 3) in the double-parental chimeras (Table VIII). All of the mice
in group III were suppressed for their IgG2a' by at least 50% ofthe prebleed levels.
3 of the 13 mice eventually showed a late recovery of their IgG2a' levels at a time
TABLE VII
Total Serum IgM Allotypes in IgM Antichromatin-positive
Double-Chimeric GVH Mice
Prebleed
￿
Peak
Group n Igh' Ighb Igh' Igh"
III
￿
10 1,0161 1,171 2,282 980
IV
￿
8 915 1,084 996 2,271
' Results shown are from bleeds with highest IgM antichromatin titers (see
Fig. 3) .
1 Arithmetic mean (tug/ml).
Group n
Prebleed
Igh' Igh' Igh'
Peak'
Ighh
I 12 2741 500 378 659
II 7 341 667 335 682
III 13 504 610 808 141
IV 12 671 659 105 1,214MORRIS ET AL.
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TABLE VIII
Allotype-specific Suppression of Total Serum IgG2a in Chimeric GVH Mice
' All mice before GVH induction had IgG2a ofboth allotypes. Suppression oc-
curred by the first bleed after GVH induction.
t Of these 21 strongly suppressed mice, eight recovered.
S Of these five partially suppressed mice, four recovered.
when most ofthe other mice had already died. Group IV mice showed a reciprocal
suppression of IgG2a'. Of additional note, 10 of 12 of the group III mice studied
by a hemagglutination assay showed a two- to fourfold reduction in IgG2bb from
their prebleed levels. This contrasts with four mice that were tested from group IV
and that showed a similar increase in their serum levels of IgG2bb.
FIGURE 4.
￿
Allotype of total serum IgG2a and
IgG2a antichromatin antibodies in an individual
chimeric GVH mouse. The antichromatin and
total IgG2a antibodies are shown for a (B6.C20
+ bm12) chimera that received B6 spleen cells
(group IV). IgG2a antichromatin antibodies were
only ofthe b allotype and peaked at 11 wk (A). To-
tal levels of IgG2a' became undetectable at 3 wk,
but returned towards normal after9 wk(B). An-
tichromatin IgG2a' (/), antichromatin IgG2ab
(A), total IgG2ab (0), and total IgG2ab (A).
Suppression'
Group n
D90%
IgG2aa IgG2ab-
X50%,
IgG2a'
but 490%
IgG2ab
I bm12-(B6.C20 x bm12)Fl 12 0 0 0 0
II B6-(B6.C20 x bm12)Fi 11 0 0 0 0
III bm12-M.C20 + bm12 13 0 111 0 2S
IV 116-136.C20 + bm12 13 101 0 3S 0512
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FIGURE 5.
￿
Allotype of total serum IgM and
IgM antichromatin antibodies in an individual
chimeric GVH mouse. The antichromatin and
0
￿
5
￿
10
￿
15
￿
total IgM antibodies areshownfora(B6.C20 +
weeks
￿
bm12) chimera that received bm12 spleen cells
(group III). IgMantichromatinantibodies were
only ofthe a allotype andpeaked at week 5 (A).
Total serum IgMa showed an early increase (at
3 wk), while IgMbdecreased somewhat (B). An-
tichromatin IgMa (/), antichromatin IgMb
(A), total IgMa (0), and total IgMb (A).
weeks
Figs. 4and 5 show serial allotype determinations in representative individual double-
parental chimeras. A double-parental chimera that received B6 spleen cells (group
IV) had IgG2ab antichromatin antibodies (Fig. 4A). Total levels ofthe IgG2a' were
totally suppressed at 3 wk, but returned during the peak IgG2a antichromatin re-
sponse, even though the antichromatin antibodies remained entirely IgG2ab (Fig.
4B). A double-parental chimera that received bm12 spleen cells (group III) showed
IgMa antichromatin antibodies (Fig. 5 A), while total levels ofIgMa increased and
IgMb decreased slightly (Fig. 5 B).
Discussion
Chronic GVH results from the administration of alloreactive donor T cells that
recognize host laand cause the selective stimulation ofB cellsthat produce autoan-
tibodies (5-7). In the current work we have investigated whether the donor T cells
must directly recognize foreign la on the B cells thatare stimulated to make autoan-
tibodies (cognate interaction), or whether such T cells can be activated by la and
then deliver sufficient help throughsoluble factors (lymphokines) that would interact
with B cells that bear the foreign Iaas wellasthosethat donot. Usingdouble-parental
chimeras, differing at both Ia and Igh allotype, we were able to distinguish suchMORRIS ET AL.
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cognate help from bystander interaction in an in vivo situation. Although we trans-
ferred whole spleen cellpopulations to initiate the GVH reaction, the donor B cells
were irrelevant, as they do not participate in this syndrome (24a).
Our resultsstrongly indicate that the cognate model ofT-B interaction is favored
for production ofautoantibodies in chronicGVH. Specifically, forboth antierythro-
cyte (Coombs) and antichromatin systems, the autoantibodies were overwhelmingly
ofthe allotypes that would result from cognate T-B collaboration. That is, double-
parental chimeras that received bm12 spleen cells made autoantibodies of the Igha
allotype, presumably as a result of the interaction of the bm12 T cells with the
lab/Igha host B cells ofB6.C20 origin. Conversely, recipients ofB6 spleen cells made
Ighb autoantibodies, indicating a cognate interaction between B6 T cells and the
Iabm"/Ighb host B cells ofbm12 origin. Cognate preference for IgG2a antichromatin
autoantibodies was absolute, while antichromatin of the IgM isotype showed low
level bystanderinduction alongwith evidence ofstrong cognate interaction. We could
not test additional isotypes because oflimitations ofaffinity ofthe antiallotype re-
agents; however, IgG2a was themain isotypeforthe antichromatin response inthese
mice, as it is in other SLE mice (24). The Coombs antibody appeared in multiple
isotypes, with no discernable pattern of isotype progression. Nevertheless, in the
vast majority of cases, the antibody allotype indicated cognate T-B interaction for
each isotype. The exceptions were three mice that received bm12 spleen cells and
yet showed IgG2aa antierythrocyte antibodies, along with a variety of b allotype
Coombs antibodies. Although this mayindicate anoccasional induction ofautoanti-
bodies by bystander mechanism, it is also possible that low level recovery of the
recipients' endogenous (B6.C20 x bm12)F, bone marrow may have permitted a al-
lotype autoantibodies through cognate interaction. Overall, then, ourdata indicate
that the Coombs and antichromatin antibodies in the GVH system are mainly pro-
duced through cognate T-B collaboration. We cannot rule out an additional weak
bystander effect in some cases, particularly for the IgM isotype.
An additional interesting finding was a relative preference for b-allotype an-
tichromatin antibodies ofboth the IgG2a and IgM isotypes in the GVH chimeras
reconstituted with F1 bone marrow. This skewing probably results from two sepa-
rate mechanisms, which we have explored indetail elsewhere (24a). First, the donor
T cells in both groups I and 11 were themselves from animals of b allotype, and
therefore would tend to suppress the B cells ofthe a allotype in the recipient. This
would not be expected to be a major factor, since such suppression ofthe a allotype
by b allotype donor cells is weak, in comparison with suppression ofb allotype by
aallotypedonor cells(25). Second, andprobablymoreimportant, isageneral favoring
of the b allotype for antichromatin antibodies that we have seen in allotype-
heterozygous spontaneous SLE mice (26; and Fisher, C. L., S. C. Morris, P L. Cohen,
andR. A. Eisenberg, manuscript inpreparation), andwhichwe have alsodocumented
in the GVH system. Although such b allotype skewingmay have contributed to the
results seen in group IV double-parental chimeras, the striking a allotype prefer-
ence forautoantibodiesin group III double-parental chimeras is counterto this ten-
dency and confirmsourinterpretation ofcognate T-B interaction. Interestingly, the
Coombs antibodies in the group II chimeras were entirelyofthe a allotype, butthere
were too few mice that responded in this group to draw any firm conclusions.
A particularly surprising result was that suppression ofthe IgG2a from the non-514
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cognately recognized B cells occurred in all ofthe double parental chimeras by the
first bleed (week 3) after GVH induction. This suppression was at least 50% ofthe
prebleed level of IgG2a, but was usually >90% of the prebleed, while the IgG2a
from the cognately recognized B cells usually showed a reciprocal increase. 8 ofthe
26 mice in the double-parental chimeras showed a late recovery oftheir suppressed
IgG2a allotype while antichromatin antibodies were still present, but the allotype
ofthese autoantibodies remained onlyofthecognate allotype. This allotype-specific
suppression is probablynotcomparable to allotypesuppression in cell transfer systems
reported by others and seen in our earlier GVH experiments (24a, 25). In all of
these cases, the transferred cells suppressed a host allotype different from that of
the cell donor, presumably by inactivation ofallotype-specific T helper cells or di-
rect downregulation ofthe B cells themselves (27-29). In the current experiments,
suppression ofIgG2ab occurred after the double-parental chimeras received spleen
cells from Ighb bm12 mice (group III). By a hemagglutination assay a majority
ofthe mice that were suppressed for IgG2ab also showed partial downregulation of
IgG2bb . IgM levels did not show any suppression, although overall IgM levels of
thecognately recognized allotypewere increased. We speculate thatthe suppression
ofthe noncognate allotype may represent an attempt to downregulate the immune
system in the setting ofautoimmunity and may parallel the hyporesponsiveness to
exogenous antigen challenge seen in the GVH model and spontaneous SLE (30-32).
In any case, the fact that there was suppression does not affect the interpretation
of a preference for direct T-B interactions for three reasons: (a) The recovery of
the suppressed allotype of IgG2a in eight strongly suppressed mice did not result
in antichromatin autoantibodies ofthat allotype; (b) thepresence ofthenoncognate
allotype in 5 mice that were only partially suppressed for IgG2a did not result in
antichromatin autoantibodies ofthat allotype; (c) the IgMantichromatinantibodies
were principally of the cognate allotype.
Our current work on autoimmunity parallels results with exogenous antigens (9,
10, 33-40). In an in vivo model cognate T-B collaboration was clearly preferred
(38). In an in vitro system IgG isotype antibodies were dependent on cognate inter-
actions, while IgMisotype could result from both cognate and bystander effects(41).
In addition low concentrations ofantigen favored cognate interactions, andthiswould
be compatible with limited availability of intracellular autoantigens.
The results shown here areconsistent with ourhypothesis regardingthe possible
mechanisms ofautoantibody productioninSLE (42). Wesuggested that the genera-
tion ofhigh titers of autoantibodies in SLE/GVH required direct recognition by
T helper cellsofB celldeterminants, and specifically that T cells saw selfnon-MHC
autoantigens complexed with an abnormally recognized Ia on the surface ofB cells
specific for such autoantigens. In the case of the alloreactive T helper cells in the
present GVHchimera model, autoantigen would be recognized in conjunction with
foreign Ia, although cognate T-B interactions could also occur ifB cell foreign Ia
were seenbyitself (43). In human SLE an alteration in lamay occurthrough muta-
tions, viruses, ordrugs, and then this would be recognized as foreign by selfT cells.
Cognate T-B interaction ofthese reactive T cells with altered Ia on autoreactive B
cells would directly stimulate such cells to produce the spectrum ofautoantibodies
typical of SLE.MORRIS ET AL.
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Summary
A chronic graft-versus-host reaction (GVH) induced in nonautoimmune mice causes
a syndrome that closely resembles SLE. In this model, donor T cells react against
incompatible host Ia structures and generate excessive help, which activates a sub-
population ofself-reactive B cells. We have studied whether these self-reactive B cells
are activated by direct interaction with alloreactive T cellsor by nonspecific bystander
effects. Two types of chimeras were made: double-parental chimeras, differing at
both la and Igh allotype [B6.C20 + bm12 -" (B6.C20 x bm12)Fl ]; and control
chimeras [(B6.C20 x bm12)Fj - (B6 .C20 x bml2)F1]. A chronic GVH syndrome
was induced in the chimeras by infusion of B6 or bm12 spleen cells. Coombs and
antichromatin autoantibodies were measured using Igh allotype-specific immuno-
assays. The double-parental chimeras that received bm12 cellsmade autoantibodies
principally of the Igha allotype, indicating that the bml2 T cells interacted only with
the Iab-bearing host B cells. Conversely, double-parental chimeras that received B6
cells made mostly Ighb autoantibodies, indicating direct cognate interaction with
the Iab' 12-bearing host B cells. The control chimeras made autoantibodies of both
allotypes. These results indicate that autoantibodies in chronic GVH result from
direct T-B interactions and not from nonspecific T cell-derived factors.
We thank Sylvia Y. Craven for help with breeding the mice. We acknowledge NCI-CB-25584
for the four Ighb myelomas obtained from Dr. Michael Potter.
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